Jonathan Langley
Uxbridge, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Phase 2b trial of inhaled imatinib for treatment of pulmonary arterial hypertension.
Journal: American journal of respiratory and critical care medicine
Published: February 19, 2025
Phase 2b trial of inhaled imatinib for treatment of pulmonary arterial hypertension.
Journal: American journal of respiratory and critical care medicine
Published: February 19, 2025
IMPAHCT: A randomized phase 2b/3 study of inhaled imatinib for pulmonary arterial hypertension.
Journal: Pulmonary circulation
Published: October 31, 2023
Epidemiology, healthcare utilization, and related costs among patients with IPF: results from a German claims database analysis.
Journal: Respiratory research
Published: October 05, 2021
Idiopathic pulmonary fibrosis: Physician and patient perspectives on the pathway to care from symptom recognition to diagnosis and disease burden.
Journal: Respirology (Carlton, Vic.)
Published: April 26, 2021
Global incidence and prevalence of idiopathic pulmonary fibrosis.
Journal: Respiratory research
Published: April 22, 2021
Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis.
Journal: Annals of the rheumatic diseases
Published: September 05, 2019
Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: Results from the AMBITION trial.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: May 17, 2019
Clinical outcomes stratified by baseline functional class after initial combination therapy for pulmonary arterial hypertension.
Journal: Respiratory research
Published: May 01, 2019
Initial combination therapy with ambrisentan + tadalafil on pulmonary arterial hypertension‒related hospitalization in the AMBITION trial.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: May 24, 2018
Risk-stratified outcomes with initial combination therapy in pulmonary arterial hypertension: Application of the REVEAL risk score.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: February 23, 2018
Initial combination therapy with ambrisentan and tadalafil and mortality in patients with pulmonary arterial hypertension: a secondary analysis of the results from the randomised, controlled AMBITION study.
Journal: The Lancet. Respiratory medicine
Published: July 21, 2016
Last Updated: 09/26/2026